Eastern Bank’s Edwards Lifesciences EW Stock Holding History

Eastern Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$120K	Hold	1,393	–	–	﹤0.01%	485
2026 Q2	$126K	Sell	1,393 -17	-1%	-$1.42K	﹤0.01%	461
2026 Q1	$113K	Sell	1,410 -91	-6%	-$7.5K	﹤0.01%	450
2025 Q4	$128K	Buy	1,501 +70	+5%	+$5.74K	﹤0.01%	428
2025 Q3	$111K	Buy	1,431 +17	+1%	+$1.33K	﹤0.01%	449
2025 Q2	$111K	Sell	1,414 -97	-6%	-$7.23K	﹤0.01%	439
2025 Q1	$110K	Buy	1,511 +71	+5%	+$5.08K	﹤0.01%	442
2024 Q4	$107K	Sell	1,440 -41	-3%	-$2.87K	﹤0.01%	457
2024 Q3	$97.7K	Buy	+1,481	New	+$108K	﹤0.01%	469

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Eastern Bank's EW Position: Q3 2026 in Review

Eastern Bank held its Edwards Lifesciences (EW) position steady in Q3 2026 at 1,393 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

Eastern Bank first reported a position in EW in Q3 2024 and has held it in 9 quarters since. The position peaked at $128K in Q4 2025. 360 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Eastern Bank held 1,393 shares of Edwards Lifesciences worth $120K as of Q3 2026.
Eastern Bank left its Edwards Lifesciences share count unchanged in Q3 2026.
Edwards Lifesciences made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #485 holding.
Eastern Bank first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 9 quarters since.
Eastern Bank's Edwards Lifesciences position peaked at $128K in Q4 2025.
360 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.